The multiple functions of TRBP, at the hub of cell responses to viruses, stress, and cancer

Microbiology and Molecular Biology Reviews

Volumn 76, Issue 3, 2012, Pages 652-666

  Daniels, Sylvanne M ^a,b   Gatignol, Anne ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; MICRORNA; RNA BINDING PROTEIN; TRANS ACTIVATION RESPONSE RNA BINDING PROTEIN 1; TRANS ACTIVATION RESPONSE RNA BINDING PROTEIN 2; UNCLASSIFIED DRUG;

CANCER GROWTH; CRYSTAL STRUCTURE; GENE OVEREXPRESSION; GENE SILENCING; GENETIC ANALYSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE RESPONSE; NEOPLASM; NONHUMAN; PHYLOGENY; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; RNA INTERFERENCE; RNA PROCESSING; SACCHAROMYCES CEREVISIAE; STRESS; VIRUS; VIRUS REPLICATION;

CELLS; GENE EXPRESSION REGULATION; HEAT-SHOCK RESPONSE; HUMANS; MUTATION; NEOPLASMS; RNA-BINDING PROTEINS; VIRUS DISEASES; VIRUSES;

EID: 84865727711     PISSN: 10922172     EISSN: 10985557     Source Type: Journal    
DOI: 10.1128/MMBR.00012-12     Document Type: Review

References (148)

1. Arnaud N, et al. 2010. Hepatitis C virus controls interferon production through PKR activation. PLoS One 5 :e10575. doi:10.1371/journal.pone.0010575.
2. Bannwarth S, Gatignol A. 2005. HIV-1 TAR RNA: the target of molecular interactions between the virus and its host. Curr. HIV Res. 3:61-71.
3. Bannwarth S, et al. 2006. Cell-specific regulation of TRBP1 promoter by NF-Y transcription factor in lymphocytes and astrocytes. J. Mol. Biol. 355:898-910.
4. Bannwarth S, et al. 2001. Organization of the human tarbp2 gene reveals two promoters that are repressed in an astrocytic cell line. J. Biol. Chem. 276:48803-48813.
5. Barber GN. 2009. The NFAR's (nuclear factors associated with dsRNA): evolutionarily conserved members of the dsRNA binding protein family. RNA Biol. 6:35-39.
6. Bass BL, Hurst SR, Singer JD. 1994. Binding properties of newly identified Xenopus proteins containing dsRNA-binding motifs. Curr. Biol. 4:301-314.
7. Battisti PL, et al. 2003. Additive activity between the trans-activation response RNA-binding protein, TRBP2, and cyclin T1 on HIV type 1 expression and viral production in murine cells. AIDS Res. Hum. Retroviruses 19:767-778.
8. Benkirane M, et al. 1997. Oncogenic potential of TAR RNA binding protein TRBP and its regulatory interaction with RNA-dependent protein kinase PKR. EMBO J. 16:611-624.
9. Bennasser Y, Le SY, Benkirane M, Jeang KT. 2005. Evidence that HIV-1 encodes an siRNA and a suppressor ofRNAsilencing. Immunity 22:607-619.
10. Bennasser Y, Yeung ML, Jeang KT. 2006. HIV-1 TAR RNA subverts RNA interference in transfected cells through sequestration of TAR RNA-binding protein, TRBP. J. Biol. Chem. 281:27674-27678.
11. Bennett RL, Blalock WL, May WS. 2004. Serine 18 phosphorylation of RAX, the PKR activator, is required for PKR activation and consequent translation inhibition. J. Biol. Chem. 279:42687-42693.
12. Blair ED, et al. 1995. Expression of TAR RNA-binding protein in baculovirus and co-immunoprecipitation with insect cell protein kinase. J. Biomed. Sci. 2:322-329.
13. Blalock WL, Bavelloni A, Piazzi M, Faenza I, Cocco L. 2010. A role for PKR in hematologic malignancies. J. Cell. Physiol. 223:572-591.
14. Blanchard D, et al. 2011. On the nature of in vivo requirements for rde-4 in RNAi and developmental pathways in C. elegans. RNA Biol. 8:458-467.
15. Bourikas D, Stoeckli ET. 2003. New tools for gene manipulation in chicken embryos. Oligonucleotides 13:411-419.
16. Braun RE. 2000. Temporal control of protein synthesis during spermatogenesis. Int. J. Androl. 23(Suppl 2):92-94.
17. Bueno MJ, Malumbres M. 2011. MicroRNAs and the cell cycle. Biochim. Biophys. Acta 1812:592-601.
18. Caballero OL, Chen YT. 2009. Cancer/testis (CT) antigens: potential targets for immunotherapy. Cancer Sci. 100:2014-2021.
19. Castanotto D, et al. 2007. Combinatorial delivery of small interfering RNAs reduces RNAi efficacy by selective incorporation into RISC. Nucleic Acids Res. 35:5154-5164.
20. Chakravarthy S, Sternberg SH, Kellenberger CA, Doudna JA. 2010. Substrate-specific kinetics of Dicer-catalyzed RNA processing. J. Mol. Biol. 404:392-402.
21. Chang KY, Ramos A. 2005. The double-stranded RNA-binding motif, a versatile macromolecular docking platform. FEBS J. 272:2109-2117.
22. Chendrimada TP, et al. 2005. TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature 436:740-744.
23. Chi YH, Semmes OJ, Jeang KT. 2011. A proteomic study of TAR-RNA binding protein (TRBP)-associated factors. Cell Biosci. 1:9.
24. Christensen HS, et al. 2007. Small interfering RNAs against the TAR RNA binding protein, TRBP, a Dicer cofactor, inhibit human immunodeficiency virus type 1 long terminal repeat expression and viral production. J. Virol. 81:5121-5131.
25. Clerzius G, et al. 2009. ADAR1 interacts with PKR during human immunodeficiency virus infection of lymphocytes and contributes to viral replication. J. Virol. 83:10119-10128.
26. Clerzius G, Gélinas JF, Gatignol A. 2011. Multiple levels of PKR inhibition during HIV-1 replication. Rev. Med. Virol. 21:42-53.
27. Cosentino GP, et al. 1995. Double-stranded-RNA-dependent protein kinase and TAR RNA-binding protein form homo- and heterodimers in vivo. Proc. Natl. Acad. Sci. U. S. A. 92:9445-9449.
28. Daher A, et al. 2009. TRBP control of PACT-induced phosphorylation of protein kinase R is reversed by stress. Mol. Cell. Biol. 29:254-265.
29. Daher A, et al. 2001. Two dimerization domains in the trans-activation response RNA-binding protein (TRBP) individually reverse the protein kinase R inhibition of HIV-1 long terminal repeat expression. J. Biol. Chem. 276:33899-33905.
30. Daniels SM, et al. 2009. Characterization of the TRBP domain required for dicer interaction and function in RNA interference. BMC Mol. Biol. 10:38.
31. Daviet L, et al. 2000. Analysis of a binding difference between the two dsRNA-binding domains in TRBP reveals the modular function of a KR-helix motif. Eur. J. Biochem. 267:2419-2431.
32. Dehal P, et al. 2002. The draft genome of Ciona intestinalis: insights into chordate and vertebrate origins. Science 298:2157-2167.
33. Desper R, Gascuel O. 2004. Theoretical foundation of the balanced minimum evolution method of phylogenetic inference and its relationship to weighted least-squares tree fitting. Mol. Biol. Evol. 21:587-598.
34. Dimitrova DI, et al. 2005. Lentivirus-mediated transduction of PKR into CD34(+) hematopoietic stem cells inhibits HIV-1 replication in differentiated T cell progeny. J. Interferon Cytokine Res. 25:345-360.
35. Donzeau M, Winnacker EL, Meisterernst M. 1997. Specific repression of Tax trans-activation by TAR RNA-binding protein TRBP. J. Virol. 71:2628-2635.
36. Dorin D, et al. 2003. The TAR RNA-binding protein, TRBP, stimulates the expression of TAR-containing RNAs in vitro and in vivo independently of its ability to inhibit the dsRNA-dependent kinase PKR. J. Biol. Chem. 278:4440-4448.
37. Doyle M, Jantsch MF. 2002. New and old roles of the double-stranded RNA-binding domain. J. Struct. Biol. 140:147-153.
38. Duarte M, et al. 2000. Characterization of TRBP1 and TRBP2. Stable stem-loop structure at the 5′ end of TRBP2 mRNA resembles HIV-1 TAR and is not found in its processed pseudogene. J. Biomed. Sci. 7:494-506.
39. Eekels JJ, Geerts D, Jeeninga RE, Berkhout B. 2011. Long-term inhibition of HIV-1 replication with RNA interference against cellular cofactors. Antiviral Res. 89:43-53.
40. Erard M, Barker DG, Amalric F, Jeang KT, Gatignol A. 1998. An Arg/Lys-rich core peptide mimics TRBP binding to the HIV-1 TAR RNA upper-stem/loop. J. Mol. Biol. 279:1085-1099.
41. Fabian MR, Sonenberg N, Filipowicz W. 2010. Regulation of mRNA translation and stability by microRNAs. Annu. Rev. Biochem. 79:351-379.
42. Fabozzi G, Nabel CS, Dolan MA, Sullivan NJ. 2011. Ebolavirus proteins suppress the effects of small interfering RNA by direct interaction with the mammalian RNA interference pathway. J. Virol. 85:2512-2523.
43. Fire A, et al. 1998. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391:806-811.
44. Förstemann K, et al. 2005. Normal microRNA maturation and germline stem cell maintenance requires Loquacious, a double-stranded RNA-binding domain protein. PLoS Biol. 3 :e236. doi:10.1371/journal.pbio.0030236.
45. Fu X, Xue C, Huang Y, Xie Y, Li Y. 2010. The activity and expression of microRNAs in prostate cancers. Mol. Biosyst. 6:2561-2572.
46. Gale M, Jr, Tan SL, Katze MG. 2000. Translational control of viral gene expression in eukaryotes. Microbiol. Mol. Biol. Rev. 64:239-280.
47. Garaigorta U, Chisari FV. 2009. Hepatitis C virus blocks interferon effector function by inducing protein kinase R phosphorylation. Cell Host Microbe 6:513-522.
48. García MA, et al. 2006. Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action. Microbiol. Mol. Biol. Rev. 70:1032-1060.
49. García MA, Meurs EF, Esteban M. 2007. The dsRNA protein kinase PKR: virus and cell control. Biochimie 89:799-811.
50. Garre P, Perez-Segura P, Diaz-Rubio E, Caldes T, de la Hoya M. 2010. Reassessing the TARBP2 mutation rate in hereditary nonpolyposis colorectal cancer. Nat. Genet. 42:817-818.
51. Gatignol A, Buckler C, Jeang KT. 1993. Relatedness of an RNA-binding motif in human immunodeficiency virus type 1 TAR RNA-binding protein TRBP to human P1/dsI kinase and Drosophila staufen. Mol. Cell. Biol. 13:2193-2202.
52. Gatignol A, Buckler-White A, Berkhout B, Jeang KT. 1991. Characterization of a human TAR RNA-binding protein that activates the HIV-1 LTR. Science 251:1597-1600.
53. Gatignol A, Duarte M, Daviet L, Chang YN, Jeang KT. 1996. Sequential steps in Tat trans-activation of HIV-1 mediated through cellular DNA, RNA, and protein binding factors. Gene Expr. 5:217-228.
54. Gatignol A, Jeang K-T. 1994. Expression cloning of genes encoding RNA binding proteins, p 18-28. In AdolphKW(ed), Methods in molecular genetics: molecular virology techniques, part A, vol 4. Academic Press, San Diego, CA.
55. Gatignol A, Lainé S, Clerzius G. 2005. Dual role of TRBP in HIV replication and RNA interference: viral diversion of a cellular pathway or evasion from antiviral immunity? Retrovirology 2:65. doi:10.1186/1742-4690-2-65.
56. Gélinas JF, Clerzius G, Shaw E, Gatignol A. 2011. Enhancement of replication of RNA viruses by ADAR1 via RNA editing and inhibition of RNA-activated protein kinase. J. Virol. 85:8460-8466.
57. Gorry PR, et al. 1999. Diminished production of human immunodeficiency virus type 1 in astrocytes results from inefficient translation of gag, env, and nef mRNAs despite efficient expression of Tat and Rev. J. Virol. 73:352-361.
58. Gorry PR, et al. 2003. Astrocyte infection by HIV-1: mechanisms of restricted virus replication, and role in the pathogenesis of HIV-1-associated dementia. Curr. HIV Res. 1:463-473.
59. Gredell JA, Dittmer MJ, Wu M, Chan C, Walton SP. 2010. Recognition of siRNA asymmetry by TAR RNA binding protein. Biochemistry 49:3148-3155.
60. Gregory RI, Chendrimada TP, Cooch N, Shiekhattar R. 2005. Human RISC couples microRNA biogenesis and posttranscriptional gene silencing. Cell 123:631-640.
61. Grishin NV. 1995. Estimation of the number of amino acid substitutions per site when the substitution rate varies among sites. J. Mol. Evol. 41:675-679.
62. Grundhoff A, Sullivan CS. 2011. Virus-encoded microRNAs. Virology 411:325-343.
63. Gu S, et al. 2011. Thermodynamic stability of small hairpin RNAs highly influences the loading process of different mammalian Argonautes. Proc. Natl. Acad. Sci. U. S. A. 108:9208-9213.
64. Gupta V, Huang X, Patel RC. 2003. The carboxy-terminal, M3 motifs of PACT and TRBP have opposite effects on PKR activity. Virology 315:283-291.
65. Haase AD, et al. 2005. TRBP, a regulator of cellular PKR and HIV-1 virus expression, interacts with Dicer and functions in RNA silencing. EMBO Rep. 6:961-967.
66. Hitti EG, Sallacz NB, Schoft VK, Jantsch MF. 2004. Oligomerization activity of a double-stranded RNA-binding domain. FEBS Lett. 574:25-30.
67. Hock J, Meister G. 2008. The Argonaute protein family. Genome Biol. 9:210.
68. Huang X, Hutchins B, Patel RC. 2002. The C-terminal, third conserved motif of the protein activator PACT plays an essential role in the activation of double-stranded-RNA-dependent protein kinase (PKR). Biochem. J. 366:175-186.
69. Hutvagner G, Simard MJ. 2008. Argonaute proteins: key players in RNA silencing. Nat. Rev. Mol. Cell Biol. 9:22-32.
70. Ito T, Yang M, May WS. 1999. RAX, a cellular activator for double-stranded RNA-dependent protein kinase during stress signaling. J. Biol. Chem. 274:15427-15432.
71. Jaskiewicz L, Filipowicz W. 2008. Role of Dicer in posttranscriptional RNA silencing. Curr. Top. Microbiol. Immunol. 320:77-97.
72. Jha BK, et al. 2011. Inhibition of RNase L and RNA-dependent protein kinase (PKR) by sunitinib impairs antiviral innate immunity. J. Biol. Chem. 286:26319-26326.
73. Jopling CL, Yi M, Lancaster AM, Lemon SM, Sarnow P. 2005. Modulation of hepatitis C virus RNA abundance by a liver-specific microRNA. Science 309:1577-1581.
74. Ketting RF. 2011. The many faces of RNAi. Dev. Cell 20:148-161.
75. Kharrat A, Macias MJ, Gibson TJ, Nilges M, Pastore A. 1995. Structure of the dsRNA binding domain of E. coli RNase III. EMBO J. 14:3572-3584.
76. Kim DH, Villeneuve LM, Morris KV, Rossi JJ. 2006. Argonaute-1 directs siRNA-mediated transcriptional gene silencing in human cells. Nat. Struct. Mol. Biol. 13:793-797.
77. Kim MS, et al. 2010. Somatic mutations and losses of expression of microRNA regulation-related genes AGO2 and TNRC6A in gastric and colorectal cancers. J. Pathol. 221:139-146.
78. Kini HK, Walton SP. 2009. Effect of siRNA terminal mismatches on TRBP and Dicer binding and silencing efficacy. FEBS J. 276:6576-6585.
79. Kok KH, Ng MH, Ching YP, Jin DY. 2007. Human TRBP and PACT directly interact with each other and associate with dicer to facilitate the production of small interfering RNA. J. Biol. Chem. 282:17649-17657.
80. Koromilas AE, Roy S, Barber GN, Katze MG, Sonenberg N. 1992. Malignant transformation by a mutant of the IFN-inducible dsRNA-dependent protein kinase. Science 257:1685-1689.
81. Koscianska E, Starega-Roslan J, Krzyzosiak WJ. 2011. The role of Dicer protein partners in the processing of microRNA precursors. PLoS One 6:e28548. doi:10.1371/journal.pone.0028548.
82. Kozak CA, Gatignol A, Graham K, Jeang KT, McBride OW. 1995. Genetic mapping in human and mouse of the locus encoding TRBP, a protein that binds the TAR region of the human immunodeficiency virus (HIV-1). Genomics 25:66-72.
83. Krol J, Loedige I, Filipowicz W. 2010. The widespread regulation of microRNA biogenesis, function and decay. Nat. Rev. Genet. 11:597-610.
84. Laraki G, et al. 2008. Interactions between the double-stranded RNA-binding proteins TRBP and PACT define the Medipal domain that mediates protein-protein interactions. RNA Biol. 5:92-103.
85. Lau PW, Potter CS, Carragher B, MacRae IJ. 2009. Structure of the human Dicer-TRBP complex by electron microscopy. Structure 17:1326-1332.
86. Lecellier CH, et al. 2005. A cellular microRNA mediates antiviral defense in human cells. Science 308:557-560.
87. Lee JY, et al. 2004. Merlin, a tumor suppressor, interacts with transactivation-responsive RNA-binding protein and inhibits its oncogenic activity. J. Biol. Chem. 279:30265-30273.
88. Lee JY, et al. 2006. Merlin facilitates ubiquitination and degradation of transactivation-responsive RNA-binding protein. Oncogene 25:1143-1152.
89. Lee K, Fajardo MA, Braun RE. 1996. A testis cytoplasmic RNA-binding protein that has the properties of a translational repressor. Mol. Cell. Biol. 16:3023-3034.
90. Lee Y, et al. 2006. The role of PACT in the RNA silencing pathway. EMBO J. 25:522-532.
91. Li S, Sen GC. 2003. PACT-mediated enhancement of reporter gene expression at the translational level. J. Interferon Cytokine Res. 23:689-697.
92. Lima WF, et al. 2009. Binding and cleavage specificities of human Argonaute2. J. Biol. Chem. 284:26017-26028.
93. Liu Q, Paroo Z. 2010. Biochemical principles of small RNA pathways. Annu. Rev. Biochem. 79:295-319.
94. Liu Q, et al. 2003. R2D2, a bridge between the initiation and effector steps of the Drosophila RNAi pathway. Science 301:1921-1925.
95. Ma E, MacRae IJ, Kirsch JF, Doudna JA. 2008. Autoinhibition of human dicer by its internal helicase domain. J. Mol. Biol. 380:237-243.
96. Maas S, Kawahara Y, Tamburro KM, Nishikura K. 2006. A-to-I RNA editing and human disease. RNA Biol. 3:1-9.
97. MacRae IJ, Ma E, Zhou M, Robinson CV, Doudna JA. 2008. In vitro reconstitution of the human RISC-loading complex. Proc. Natl. Acad. Sci. U. S. A. 105:512-517.
98. Mallanna SK, et al. 2006. Inhibition of anatid herpes virus-1 replication by small interfering RNAs in cell culture system. Virus Res. 115:192-197.
99. Maniataki E, Mourelatos Z. 2005. A human, ATP-independent, RISC assembly machine fueled by pre-miRNA. Genes Dev. 19:2979-2990.
100. Melo S, et al. 2011. Small molecule enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2-mediated microRNA processing. Proc. Natl. Acad. Sci. U. S. A. 108:4394-4399.
101. Melo SA, et al. 2009. A TARBP2 mutation in human cancer impairs microRNA processing and DICER1 function. Nat. Genet. 41:365-370.
102. Meurs E, et al. 1990. Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon. Cell 62:379-390.
103. Meurs EF, Galabru J, Barber GN, Katze MG, Hovanessian AG. 1993. Tumor suppressor function of the interferon-induced double-stranded RNA-activated protein kinase. Proc. Natl. Acad. Sci. U. S. A. 90:232-236.
104. Mounir Z, Koromilas AE. 2010. Uncovering the PKR pathway's potential for treatment of tumors. Future Oncol. 6:643-645.
105. Murphy D, Dancis B, Brown JR. 2008. The evolution of core proteins involved in microRNA biogenesis. BMC Evol. Biol. 8:92.
106. Nie Y, Hammond GL, Yang JH. 2007. Double-stranded RNA deaminase ADAR1 increases host susceptibility to virus infection. J. Virol. 81:917-923.
107. Nishikura K. 2010. Functions and regulation of RNA editing by ADAR deaminases. Annu. Rev. Biochem. 79:321-349.
108. Noland CL, Ma E, Doudna JA. 2011. siRNA repositioning for guide strand selection by human Dicer complexes. Mol. Cell 43:110-121.
109. Ong CL, et al. 2005. Low TRBP levels support an innate human immunodeficiency virus type 1 resistance in astrocytes by enhancing the PKR antiviral response. J. Virol. 79:12763-12772.
110. Papadopoulos JS, Agarwala R. 2007. COBALT: constraint-based alignment tool for multiple protein sequences. Bioinformatics 23:1073-1079.
111. Pare JM, et al. 2009. Hsp90 regulates the function of argonaute 2 and its recruitment to stress granules and P-bodies. Mol. Biol. Cell 20:3273-3284.
112. Park H, et al. 1994. TAR RNA-binding protein is an inhibitor of the interferon-induced protein kinase PKR. Proc. Natl. Acad. Sci. U. S. A. 91:4713-4717.
113. Parker GS, Maity TS, Bass BL. 2008. dsRNA binding properties of RDE-4 and TRBP reflect their distinct roles in RNAi. J. Mol. Biol. 384:967-979.
114. Paroo Z, Ye X, Chen S, Liu Q. 2009. Phosphorylation of the human microRNA-generating complex mediates MAPK/Erk signaling. Cell 139:112-122.
115. Patel CV, Handy I, Goldsmith T, Patel RC. 2000. PACT, a stress-modulated cellular activator of interferon-induced double-stranded RNA-activated protein kinase, PKR. J. Biol. Chem. 275:37993-37998.
116. Patel RC, Sen GC. 1998. PACT, a protein activator of the interferon-induced protein kinase, PKR. EMBO J. 17:4379-4390.
117. Perdiguero B, Esteban M. 2009. The interferon system and vaccinia virus evasion mechanisms. J. Interferon Cytokine Res. 29:581-598.
118. Perron MP, Provost P. 2009. Protein components of the microRNA pathway and human diseases. Methods Mol. Biol. 487:369-385.
119. Peters GA, Hartmann R, Qin J, Sen GC. 2001. Modular structure of PACT: distinct domains for binding and activating PKR. Mol. Cell. Biol. 21:1908-1920.
120. Peters GA, Li S, Sen GC. 2006. Phosphorylation of specific serine residues in the PKR activation domain of PACT is essential for its ability to mediate apoptosis. J. Biol. Chem. 281:35129-35136.
121. Pindel A, Sadler A. 2011. The role of protein kinase R in the interferon response. J. Interferon Cytokine Res. 31:59-70.
122. Rossi JJ. 2005. Mammalian Dicer finds a partner. EMBO Rep. 6:927-929.
123. Rouleau GA, et al. 1993. Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature 363:515-521.
124. Rowe TM, Rizzi M, Hirose K, Peters GA, Sen GC. 2006. A role of the double-stranded RNA-binding protein PACT in mouse ear development and hearing. Proc. Natl. Acad. Sci. U. S. A. 103:5823-5828.
125. Sadler AJ, Williams BR. 2007. Structure and function of the protein kinase R. Curr. Top. Microbiol. Immunol. 316:253-292.
126. Sakurai K, et al. 2011. A role for human Dicer in pre-RISC loading of siRNAs. Nucleic Acids Res. 39:1510-1525.
127. Sanghvi VR, Steel LF. 2011. The cellular TAR RNA binding protein, TRBP, promotes HIV-1 replication primarily by inhibiting the activation of double-stranded RNA-dependent kinase PKR. J. Virol. 85:12614-12621.
128. Sanghvi VR, Steel LF. 2011. A re-examination of global suppression of RNA interference by HIV-1. PLoS One 6 : e17246. doi:10.1371/journal.pone.0017246.
129. Saunders LR, Barber GN. 2003. The dsRNA binding protein family: critical roles, diverse cellular functions. FASEB J. 17:961-983.
130. Scoles DR. 2008. The merlin interacting proteins reveal multiple targets for NF2 therapy. Biochim. Biophys. Acta 1785:32-54.
131. Shan G, et al. 2008. A small molecule enhances RNA interference and promotes microRNA processing. Nat. Biotechnol. 26:933-940.
132. Siffroi JP, et al. 2001. Expression of the TAR RNA binding protein in human testis. Mol. Hum. Reprod. 7:219-225.
133. Singh M, Castillo D, Patel CV, Patel RC. 2011. Stress-induced phosphorylation of PACT reduces its interaction with TRBP and leads to PKR activation. Biochemistry 50:4550-4560.
134. Soifer HS, et al. 2008. A role for the Dicer helicase domain in the processing of thermodynamically unstable hairpin RNAs. Nucleic Acids Res. 36:6511-6522.
135. St Johnston D, Brown NH, Gall JG, Jantsch M. 1992. A conserved double-stranded RNA-binding domain. Proc. Natl. Acad. Sci. U. S. A. 89:10979-10983.
136. Suh N, Blelloch R. 2011. Small RNAs in early mammalian development: from gametes to gastrulation. Development 138:1653-1661.
137. Suk K, et al. 2011. Reconstitution of human RNA interference in budding yeast. Nucleic Acids Res. 39:e43. doi:10.1093/nar/gkq1321.
138. Tabara H, Yigit E, Siomi H, Mello CC. 2002. The dsRNA binding protein RDE-4 interacts with RDE-1, DCR-1, and a DExH-box helicase to direct RNAi in C. elegans. Cell 109:861-871.
139. Tebit DM, Arts EJ. 2011. Tracking a century of global expansion and evolution of HIV to drive understanding and to combat disease. Lancet Infect. Dis. 11:45-56.
140. Trofatter JA, et al. 1993. A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 72:791-800.
141. Vorburger SA, et al. 2005. Gene therapy with E2F-1 up-regulates the protein kinase PKR and inhibits growth of leiomyosarcoma in vivo. Mol. Cancer Ther. 4:1710-1716.
142. Wang HW, et al. 2009. Structural insights into RNA processing by the human RISC-loading complex. Nat. Struct. Mol. Biol. 16:1148-1153.
143. Wang S, Chen AJ, Shi LJ, Zhao XF, Wang JX. 2012. TRBP and eIF6 homologue in Marsupenaeus japonicus play crucial roles in antiviral response. PLoS One 7:e30057. doi:10.1371/journal.pone.0030057.
144. Wang S, Liu N, Chen AJ, Zhao XF, Wang JX. 2009. TRBP homolog interacts with eukaryotic initiation factor 6 (eIF6) in Fenneropenaeus chinensis. J. Immunol. 182:5250-5258.
145. Wickham L, Duchaine T, Luo M, Nabi IR, DesGroseillers L. 1999. Mammalian staufen is a double-stranded-RNA- and tubulin-binding protein which localizes to the rough endoplasmic reticulum. Mol. Cell Biol. 19:2220-2230.
146. Yamashita S, et al. 2011. Structures of the first and second double-stranded RNA-binding domains of human TAR RNA-binding protein. Protein Sci. 20:118-130.
147. Zhong J, Edelhoff S, Disteche C, Braun RE. 1998. The gene encoding PRBP, the mouse homolog of human TRBP, maps to distal chromosome 15. Mamm. Genome 9:413-414.
148. Zhong J, Peters AH, Lee K, Braun RE. 1999. A double-stranded RNA binding protein required for activation of repressed messages in mammalian germ cells. Nat. Genet. 22:171-174.